Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.

A review of nutrition in Duchenne muscular dystrophy.

Davidson ZE, Truby H.

J Hum Nutr Diet. 2009 Oct;22(5):383-93. doi: 10.1111/j.1365-277X.2009.00979.x. Review.

PMID:
19743977
2.

Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols.

Biggar WD, Politano L, Harris VA, Passamano L, Vajsar J, Alman B, Palladino A, Comi LI, Nigro G.

Neuromuscul Disord. 2004 Sep;14(8-9):476-82.

PMID:
15336688
3.

Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Moxley RT 3rd, Ashwal S, Pandya S, Connolly A, Florence J, Mathews K, Baumbach L, McDonald C, Sussman M, Wade C; Quality Standards Subcommittee of the American Academy of Neurology; Practice Committee of the Child Neurology Society.

Neurology. 2005 Jan 11;64(1):13-20.

PMID:
15642897
4.

Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy.

Tarnopolsky MA, Mahoney DJ, Vajsar J, Rodriguez C, Doherty TJ, Roy BD, Biggar D.

Neurology. 2004 May 25;62(10):1771-7.

PMID:
15159476
5.

CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy.

Escolar DM, Buyse G, Henricson E, Leshner R, Florence J, Mayhew J, Tesi-Rocha C, Gorni K, Pasquali L, Patel KM, McCarter R, Huang J, Mayhew T, Bertorini T, Carlo J, Connolly AM, Clemens PR, Goemans N, Iannaccone ST, Igarashi M, Nevo Y, Pestronk A, Subramony SH, Vedanarayanan VV, Wessel H; CINRG Group.

Ann Neurol. 2005 Jul;58(1):151-5.

PMID:
15984021
6.

Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study.

Felber S, Skladal D, Wyss M, Kremser C, Koller A, Sperl W.

Neurol Res. 2000 Mar;22(2):145-50.

PMID:
10763500
7.

Nutritional therapy improves function and complements corticosteroid intervention in mdx mice.

Payne ET, Yasuda N, Bourgeois JM, Devries MC, Rodriguez MC, Yousuf J, Tarnopolsky MA.

Muscle Nerve. 2006 Jan;33(1):66-77.

PMID:
16149047
8.

Efficacy and tolerance of gastrostomy feeding in Duchenne muscular dystrophy.

Martigne L, Seguy D, Pellegrini N, Orlikowski D, Cuisset JM, Carpentier A, Tiffreau V, Guimber D, Gottrand F.

Clin Nutr. 2010 Feb;29(1):60-4. doi: 10.1016/j.clnu.2009.06.009. Epub 2009 Jul 15.

PMID:
19608306
9.

Clinical use of creatine in neuromuscular and neurometabolic disorders.

Tarnopolsky MA.

Subcell Biochem. 2007;46:183-204. Review.

PMID:
18652078
10.

Impact of corticotherapy, nutrition, and sleep disorder on quality of life of patients with Duchenne muscular dystrophy.

Jeronimo G, Nozoe KT, Polesel DN, Moreira GA, Tufik S, Andersen ML.

Nutrition. 2016 Mar;32(3):391-3. doi: 10.1016/j.nut.2015.09.004. Epub 2015 Sep 30.

PMID:
26701140
11.

Nutritional aspects of neuromuscular diseases.

McCrory MA, Wright NC, Kilmer DD.

Phys Med Rehabil Clin N Am. 1998 Feb;9(1):127-43. Review.

PMID:
9894137
12.

Nutrition Considerations in Duchenne Muscular Dystrophy.

Davis J, Samuels E, Mullins L.

Nutr Clin Pract. 2015 Aug;30(4):511-21. doi: 10.1177/0884533615586202. Epub 2015 May 14. Review.

PMID:
25977513
13.

Low bone mineral density and decreased bone turnover in Duchenne muscular dystrophy.

Söderpalm AC, Magnusson P, Ahlander AC, Karlsson J, Kroksmark AK, Tulinius M, Swolin-Eide D.

Neuromuscul Disord. 2007 Dec;17(11-12):919-28. Epub 2007 Jul 12.

PMID:
17627820
14.

Duchenne muscular dystrophy.

Yiu EM, Kornberg AJ.

Neurol India. 2008 Jul-Sep;56(3):236-47. Review.

15.

Oral glutamine and amino acid supplementation inhibit whole-body protein degradation in children with Duchenne muscular dystrophy.

Mok E, Eléouet-Da Violante C, Daubrosse C, Gottrand F, Rigal O, Fontan JE, Cuisset JM, Guilhot J, Hankard R.

Am J Clin Nutr. 2006 Apr;83(4):823-8.

16.

[Prednisolone treatment for Duchenne muscular dystrophy].

Shimomura H, Fujii T, Miyajima T, Kumada T, Kimura N, Oda N, Saito K.

No To Hattatsu. 2011 Jan;43(1):24-9. Japanese.

PMID:
21400928
17.

Therapeutics in duchenne muscular dystrophy.

Strober JB.

NeuroRx. 2006 Apr;3(2):225-34. Review.

18.

Cognitive and psychological profile of males with Becker muscular dystrophy.

Young HK, Barton BA, Waisbren S, Portales Dale L, Ryan MM, Webster RI, North KN.

J Child Neurol. 2008 Feb;23(2):155-62. Epub 2007 Dec 3.

PMID:
18056690
19.

Taking steps towards reducing osteoporosis in Duchenne muscular dystrophy.

Bachrach LK.

Neuromuscul Disord. 2005 Jan;15(1):86-7. Epub 2004 Nov 26. Review. No abstract available.

PMID:
15639126
20.

Duchenne muscular dystrophy: Canadian paediatric neuromuscular physicians survey.

McMillan HJ, Campbell C, Mah JK; Canadian Paediatric Neuromuscular Group.

Can J Neurol Sci. 2010 Mar;37(2):195-205.

PMID:
20437929

Supplemental Content

Support Center